Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Fechter Karoline |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Pansy, K,; Fechter, K.; Arra, A; Szmyra, M; Haingartner, S; Ramsay, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 is associated with higher expression of immune checkpoint components and reduced T cell-mediated lymphoma cell killing in aggressive lymphoma
HemaSphere 6():p 127-128, June 2022.. 2022; -EHA Research Conference 2022; JUN 9-12, 2022; Vienna.
[Oral Communication]
FullText
Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA
Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039.-64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 10-13, 2022; New Orleans, LA.
Doi: 10.1182/blood-2022-163034
[Poster]
Web of Science
FullText
FullText_MUG
Feichtinger, J; Fechter, K; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic NR4A1 in Diffuse Large B Cell Lymphoma
5th International CCS Workshop and 15th International CLL Workshop Salzburg 2019; APR 5-6, 2019; Fuschl am See. 2019.
[Poster]
Feichtinger, J;
Fechter, K;
Prochazka, K;
Unterluggauer, JJ;
Pansy, K;
Steinbauer, E;
Pichler, M;
Haybaeck, J;
Prokesch, A;
Greinix, HT;
Beham-Schmid, C;
Neumeister, P;
Thallinger, GG;
Deutsch, AJA;
Cytoplasmic NR4A1 in aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019.
[Poster]
Pansy, K; Ehall, B; Pursche, B; Greinix, H; Prochazka, K; Beham-Schmid, C; Neumeister, P; Deutsch, A; Fechter, K
THE CXCR4-CXCL12 AXIS IS IMPLICATED IN THE BONE MARROW INFILTRATION PROCESS OF DLBCL AND ITS ANTAGONISTS POSSESS PRO-APOPTOTIC EFFECTS IN VITRO
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019.
[Poster]
Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135.
[Oral Communication]
Web of Science
Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A;
Tumor suppressive function of Nr4a1 is mediated by regulation of Pd1-Pdl1-Pdl2 and Ctla4-Cd80-Cd86 axis in aggressive lymphomas
ÖGMBT Annual Meeting; SEP 16-18, 2019; Salzburg, AUSTRIA. 2019.
[Oral Communication]
Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck,J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, AJ;
Tumor suppressive function of Nr4a1 is mediated by the regulation of immune checkpoints in aggressive lymphomas
ÖGAI Annual Meeting; NOV 21-23; 2019; Graz, AUSTRIA. 2019.
[Oral Communication]
Pansy, K; Fechter, K; Wenzl, K; Greinix, H; Prochazka, K; Haybäck, J; Prokesch, A; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in immune escape by regulating the Pd1-Pdl1-Pdl2 and Ctla4-Cd80-Cd86 axis in aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019.
[Poster]
Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Greinix, H; Prochazka, K; Beham-Schmid, C; Neumeister, P; Wrodnigg, T; Fechter, K; Deutsch, AJ;
Deregulated CXCR4-CXCL12 Signaling Impacts on the Pathogenesis of DLBCL
Lymphoma Biology-Non-Genetic Studies. 2019; -61st ASH Annual Meeting & Exposition; DEZ 7-10, 2019; Orlando, Florida, USA.
[Poster]
FullText
Brauchart, T; Bergmann, TC; Pansy, K; Fechter, K; Greinix, H; Neumeister, P; Deutsch, A
Starvation increases the anticancer activity of Ibrutinib in ABC-DLBCL cells in vitro
ONCOL RES TREAT. 2018; 41: 81-81.-DGHO; Oktober 2018; wien.
[Poster]
Web of Science
Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P
Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82.
[Poster]
Web of Science
Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
Fechter, K; Pansy, K; Hauer, A; Kargl, J; Krogsdam, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A
Nr4a1 has as a tumor suppressive function in Myc-driven lymphomagenesis by altering the tumor microenvironment
ONCOL RES TREAT. 2018; 41: 82-82.-DHGO; Oktober 2018; Wien.
[Poster]
Web of Science
Fechter, K; Pansy, K; Hauer, A; Kargl, U; Korgsdam,A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A
Nr4a1 weist eine tumor-suppressive Rolle in der Lymphomenstehung auf und verändert das Mikromilieu der respektiven Tumore"
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28 - OCT 2, 2018; VIENNA, AUSTRIA. 2018.
[Poster]
Fechter, K; Pansy, K; Wenzl, K; Prochazka, K;Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
Frühjahrstagung der Österreichischen Gesellschaff für Hämatologie und Medizinische Onkologie
; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A
Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81.
[Poster]
Web of Science
Pansy,K; Fechter,K ; Greinix, H; Prochazka,K; Neumeister,P; Deutsch,A
Loss of Nr4a1 causes up-regulation of Nr4a3 and partially over-expression of p53 in Myc-driven lymphomagenesis
; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P
Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50.
[Poster]
Web of Science
Unterluggauer, J; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J;
Molecular expression analysis reveals potential of translation initiation factors to serve as novel biomarkers for aggressive B-cell lymphomas.
Der Pathologe 39:67-68. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26, 2018; Berlin, GERMANY.
[Oral Communication]
FullText
Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164.
[Poster]
Web of Science
Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Rinner, B; Pichler, M; Weniger, M; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J
Specific translation initiation factors influence clinical course of aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2018; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Oral Communication]
Deutsch, A; Pursche, B; Ehall, B; Zoidl, M; Fechter, K; Steinbauer, E; Sedej, M; Greinix, H; Prochazka, K; Wrodnigg, T; Beham-Schmid, C; Neumeister, P;
CXCR4 AND CXCL12 ARE IMPLICATED IN BONE MARROW INFILTRATION PROCESS OF AGGRESSIVE B CELL LYMPHOMAS AND THEIR INHIBITION SUPPRESSES LYMPHOMA CELL GROWTH IN VITRO.
HAEMATOLOGICA. HAEMATOLOGICA102: 572-572. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 22nd Congress of the European-Hematology-Association, Madrid, SPAIN, JUN 22-25, 2017)
Web of Science
Ehall, B; Pursche, B; Greinix, H; Prochazka, K; Sedej, M; Zoidl, M; Wroddnigg, T; Neumeister, P; Deutsch, A; Fechter, K;
Treatment of lymphoma cell lines with CXCR4 antagonists inhibits cell growth in vitro
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Fechter K
A short history of immunotherapy
Cell Culture Days 2017; May 31- JUN 1, 2017; Graz, Austria. 2017.
[Oral Communication]
Fechter, K;, Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; SEP 29 - OCT 3, 2017 ; Stuttgart, GERMANY. 2017.
[Oral Communication]
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
Pansy, K; Fechter, K; Greinix, H; Prochazka, K; Neumeister, P; Deutsch, A
Nr4a1 is implicated in gene regulation in a context specific manner in non-malignant lymphoid tissue
http://www.oegho.at/online-services/veranstaltungen/oegho-fruehjahrstagung-2017/fruehjahrstagung-2017.html. 2017; -OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]
Uhl, B; Wenzl, K; Fechter, K; Prochazka, KT; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, A;
CCR7 expression is associated to favourable cancer specific survival of aggressive lymphoma patients.
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Unterluggauer, J; Beham-Schmid, C; Sill, H; Tomazic, PV; Fechter, K; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Retrospective study: Expression analysis in malignant lymphomas reveals eIF impact.
International Student Congress Graz; MAY 25-27, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Unterluggauer, J; Beham-Schmid, C; Sill, H; Tomazic, PV; Fechter, K; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Expression analysis indicates implication of translation initiation factors in development of aggressive B-cell lymphomas.
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Unterluggauer, J; Beham-Schmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J;
Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas.
29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, NETHERLANDS. 2017.
[Oral Communication]
Unterluggauer, J; Beham-Schmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas
VIRCHOWS ARCH. 2017; 471: S43-S43.
[Poster]
Web of Science
Unterluggauer, J; Beham-Scmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Comprehensive expression analysis indicates translation initiation factors as novel biomarkers for aggressive B-cell lymphomas.
Herbsttagung der ÖGPath/IAP Austria; SEP 14-16, 2017; Velden, AUSTRIA. 2017.
[Poster]
Unterluggauer, J; Seeboeck, R; Tomazic, PV; Huber, HJ; Fechter, K; Steinbauer, E; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Comprehensive expression analysis indicates translation initiation factors as novel biomarkers for aggressive B-cell lymphomas
Doctoral Day 2017 Medical University of Graz; DEZ 13, 2017; Graz, AUSTRIA. 2017.
[Poster]
Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P
NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1
Blood. 2016; -58th Anual Meeting of the American Society of Hematology; Dec 3-6, 2016; San Diego, CA, USA.
[Poster]
Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P;
NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016)
Doi: 10.1182/blood.V128.22.2728.2728
Web of Science
FullText
FullText_MUG
Fechter, K
Chimeric Antigen Receptor (CAR) T cells for the treatment of B cell malignancies
CBmed: 1st Biomarker Conference Graz
From Biomarker Research to Personalized Medicine; FEB 11, 2016; Graz, Austria. 2016.
[Oral Communication]
Fechter, K
Chimeric Antigen Receptor (CAR) T cells for the treatment of B cell malignancies
CBmed: 1st Biomarker Conference Graz
From Biomarker Research to Personalized Medicine; FEB 11, 2016; Graz, Austria. 2016.
[Oral Communication]
Fechter K
T cell culture for research purposes
Cell Culture Days 2016; Apr 28-29, 2016; Graz, Austria. 2016.
[Oral Communication]
Fechter K
Immunoregulation of T cells in vitro
Cell Culture Days 2016; Apr 28-29, 2016; Graz, Austria. 2016.
[Oral Communication]
Fechter, K; Deutsch, AJA; Neumeister P
Chimeric antigen receptors for the treatment of hematologic malignancies
CBmed: 1st Biomarker Conference Graz
From Biomarker Research to Personalized Medicine; FEB 11, 2016; Graz, Austria. 2016.
[Poster]
Nikam, A; Abuja, PM; Patankar, JV; Fechter, K; Lackner, C; Schöck, E; Kratky, D; Zatloukal, K
Mitochondrial Dysfunction at the Transition between Acute and Adaptive Long-term Hepatotoxicity in Mice.
4th ÖGMBT Annual Meeting; SEP 17-19, 2012; Graz. 2012.
[Poster]
Abuja, PM; Fechter, K; Stumptner, C; Denk, H; Zatloukal, K
A Novel Antioxidant Mechanism of Bilirubin: Inhibition of the Production of Reactive Oxygen Species (ROS) by Cytochromes P450 2A5 and 2E1 in Endoplasmic Reticulum and Inner Mitochondrial Membrane
1. International Pediatric Biomarker Symposium; FEB 4-6, 2010; Innsbruck-Igls, Austria. 2010.
[Oral Communication]
Nikam, A; Fechter, K; Schöck, E; Zatloukal, K; Abuja, PM
ROS Production During a Time Course Study in a Mouse Model for Non-Alcoholic Steatohepatitis (NASH)
Annual Meeting of the ÖGMBT; SEP 27-29, 2010; Vienna. 2010.
[Poster]
Abuja, PM; Fechter, K; Denk, H; Zatloukal, K
Bilirubin Strongly Inhibits Formation of H2O2 in Endoplasmic Reticulum and Mitochondria From Mouse Liver
Gordon Research Conference Oxygen Radicals; FEB 3-8, 2008; Ventura, California, USA. 2008.
[Poster]
Fechter, K; Zatloukal, K; Denk, H; Abuja, PM
H2O2 and Mitochondrial O2.- production.
Life Sciences 2008; SEP 22-24, 2008; Graz, AUSTRIA. 2008.
[Poster]
Fechter, K; Zatloukal, K; Abuja, PM
Dependence of mitochondrial superoxide production on exogenous H2O2 concentrations
3rd International Symposium of the HNMRC, Hermann Esterbauer Memorial Meeting; Oct 15 18, 2007; Graz, Austria. 2007.
[Poster]